Multifocal Choroiditis (MFC) patients with inflammatory choroidal neovascularization (iCNV) face challenges in visual and treatment outcomes. A recently published study delves into the effectiveness of Immunomodulatory Therapy (IMT) compared to an approach using steroids as needed, shedding light on visual and treatment outcomes. This study was published in the American Journal of Ophthalmology by Matteo Airaldi and colleagues.
Immunomodulatory Therapy Outperforms Steroids in Multifocal Choroiditis Patients with Choroidal Neovascularization
Posted in biotech/medical